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Nocturnal n I
support in the m nagement
of daytime hyperc
respiratory failur
Nasal ventilation is becoming increasingly
recognised asan effective therapeutic strategy
to minimise or correct hypercapnia in patients
with respiratory failure. Intervention may be
required on a shortar long term basis. In the
majarityof patients, respiratoryfailure develops
initially during sleep. Assessing patients at risk
of nocturnal hypoventilation, and instituting
appropriate therapy, isbecoming an increasingly
important aspect of respiratorycare. This review
outlines methods and practices involved in
commencing nasal ventilationtherapy. Twenty-
nine patients presenting with hypercapnic
respiratoryfailurewere managed with nocturnal
nasal ventilation over a 12 month period. With
the use of this therapy PaCOzfell from 64(2) to
50(1 )mmHg. (.Mean. (SE.; (.p.< 0.0.01 LWhi.le p.aO~
improved from 55(2) to 68(2)mmHg(p <0.001 }
during a mean ventilation time of 1O(O.8} days.
Those factors which must be addressed for a
successful program outcome are discussed.
[Piper AJ and Willson GN: Nocturnal nasal
ventilatory support in the management of
daytime hypercapnic respiratory failure.
Australian Journal ofPhysiotherapy 42: 17-29]
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isability and death from chronic
respiratory failure and
hypercapnia are commonly seen
in patients with neuromuscular and
skeletal disorders affecting the chest
wall. Until a decade ago, treatment for
chronic respiratory failure of this
nature involved support of breathing,
usually during sleep, with either
negative pressure devices such as the
iron lung or cuirass (Garay et a11981,
Goldstein etaI1987),or with positive
pressure through a tracheostomy
(Hoeppner et alI984).However, both
forms of treatment involve major
limitations and lifestyle modifications.
The upper airway obstruction induced
by the suction effects of negative
pressure devices (Ellis etall987) and
the increased morbidity and
complication of care associated with
the introduction of tracheostomy has
limited the application of these two
modalities of therapy.
In 1987, the first published reports of
the use of nasal positive pressure
ventilation (NIPPV) began to appear
in the English literature (Ellis et al
1987, Ellis et aI1988). The ability to
comfortably and effectively deliver
positive pressure through a face mask
came about from the development ofa
mask to deliver nasal continuous
positive airway pressure (NCPAP) to
patients with obstructive sleep apnea
(Sullivanetal 1981).
Since that time, the effectiveness and
acceptability of nasal ventilatory
support for domiciliary use has been
convincingly demonstrated and it is
now considered to be the first choice
of therapy for patients with
neuromuscular and chest wall disorders
requiring home ventilation. The role
ofnocturnal nasal ventilatory support
has greatly expanded, and·now is being
used to manage patients with
hypercapnic respiratory failure from a
wider range of pathologies in various
clinical situations. This paper outlines
how sleep disordered breathing can
produce abnormalities of daytime
respiration and function, then discusses
the experience and outcomes of nasal
ventilatory support in its various
applications in clinical practice. As·the
medical community becomes
increasingly aware of the role of
abnormal nocturnal breathing in the
development of daytime respiratory
failure and disability, lmowledge and
skill in applying non-invasive
ventilatory support will become
mandatory in the comprehensive
management of patients with chronic
respiratory failure. Physiotherapists are
well placed to contribute to the
assessment and ongoing care of
patients requiring this therapy.
Sleep and breathing
Initially, abnormal breathing becomes
apparent during rapid eye movement
(REM) sleep, when there is spinal
inhibition of all postural muscles,
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producing atonia of the accessory and
intercostal respiratory muscles.. This
leaves the diaphragm to provide the
bulk of ventilatory effort.. The
breathing pattern becomes irregular,
especially during periods of phasic eye
movements. During this time, some
degree of hypoventilation is seen even
in normal subjects, whereby a 2-3 per
cent fall in oxygen saturation (Sa02)
and a 5-7mmHg rise in carbon dioxide
(PaC02) can occur (Douglas 1984,
Muller et al 1980). If the diaphragm is
weak or working at a mechanical
disadvantage, as in scoliosis, the
individual will be unable to generate
sufficient pressure to maintain
adequate ventilation. Oxygen
saturation will then fall significantly
and PaC02 will continue to rise until
the subject arouses. An arousal is a
short period of wakefulness (less than
10 seconds), in which ventilation and
postural muscle activity is increased.
During this time the accessory muscles
will be recruited and ventilation can be
restored (Figure 1). The arousal
response is a protective reflex to
minimise alterations in blood gases.
However, over time, sleep deprivation
and fragmentation appear to blunt this
reflex so that higher levels of CO) and
lower levels of oxygen are needed
before arousal occurs. With longer
periods of abnormal breathing and
hence deranged blood gases, the drive
to breathe is also depressed not only
during sleep but eventually during
wakefulness as well, possibly as a result
of chemoreceptor adaptation (Berthon
Jones and Sullivan 1987, Garay et al
1981). This sets up a vicious cycle of
depressed drive to breathe, greater
periods of abnormal breathing and
more sleep fragmentation, to the point
where respiration is grossly abnormal
both at night and during the day.
Without intervention, disability and
death from hypercapnic respiratory
failure will eventually occur (Piper and
Sullivan 1994a).
There is no simple daytime test
available to determine if nocturnal
hypoventilation is present and to what
degree. Serial daytime arterial blood
gases, along with spirometric and
Figure 1.
Part of a sleep study recording from a patient with Duchenne muscular dystrophy. The
recording channels include: electoencephalogram (EEG), electrooculogram (EOG),
electromyograms of the genioglossus (EMGgg), diaphragm (EMGdia), sternomastoid
(EMGst) and abdominal (EMGabd) muscle groups. During non-rapid eye movement
(NREM) sleep (Panel A), recruitment of the sternomastoid muscles during inspiration and
the abdominal muscles during e}q]~ration occurs to rnaintain chest wall movement With
the onset of rapid eye movement (REM) sleep (Panel B), marked reduction in accessory
muscle activity results in a reduction in chest \Nall movement until arousal. Although
arousal permits the reactivation of the accessory muscles and recovery of ventHation, it
also causes sleep disruption.
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inspiratory muscle strength
measurements, areinaportant
indicators of the likelihood that
nocturnal hypoventilation may be
present. However, only sleep studies
monitoring respiratory variables can
confirm this (Bye et a11990, Piper and
Sullivan 1994a).
Indications for nasal ventilatory
support
Nasal ventilatory support provides a
means by which abnormal breathing at
night can be corrected in a non-
invasive fashion. Generally, the
technique is well accepted by the
patient, who will continue to be
compliant with treatment if the
inconveniences involved (ie using a
mask) are compensated for by
improvements in exercise tolerance
and overall sense of wellbeing.
However, it is becoming increasingly
clear that the usefulness of nasal
ventilatory support is not confined
simply to those patients with chronic
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respiratory failure from chest wall
restriction requiring home ventilation.
The technique is now being seen as a
realistic alternative to invasive
ventilation in a number of clinical
situations, and can be offered to
patients for whom treatment was
previously considered inappropriate
because their condition was regarded
as endstage and therefore hypercapnia
was inevitable (Table 1).
Chronic respiratory failure
Use of nasal ventilatory support is
indicated for patients with symptoms
of hypoventilation and daytime CO2
retention as a consequence of a wide
number of disorders affecting the
muscles or the mechanics of the chest
wall. Its role in patients with chest wall
deformity (such as scoliosis or
thoracoplasty) and stable
neuromuscular disease (poliomyelitis,
various myopathies, spinal muscular
atrophy and spinal cord trauma) has
been well established with almost 10
years of experience with these
disorders. Use of nasal ventilatory
support nocturnally has been shown to
improve daytime blood gases (Ellis et
a11987, Leger et al 1994), sleep quality
(Elliott et a11992, Ellis et a11987, Ellis
et al 1988 ), and exercise tolerance
(Carroll and Branthwaite 1988). In
contrast, use of oxygen therapy in such
patients is rarely successful long term
(Garay et a11981) and indeed may
contribute to the problem of nocturnal
CO2 retention by prolonging the
periods of abnormal breathing
(Figure 2).
A more controversial indication for
NIPPV is its use in patients with
chronic airflow limitation (CAL).
Elliott and co-workers (1992)
investigated the feasibility of
domiciliary NIPPV in 12 patients with
stable hypercapnic respiratory failure
and CAL, looking at its effects on sleep
and quality of life. At 12 months, seven
patients continued to use the device on
a regular basis, and at the completion
of the study requested to remain on
nocturnal ventilatory support because
of the symptomatic improvement they
had experienced. Mean nocturnal Sa02
and transcutaneous carbon dioxide
(TcC02) improved considerably with
treatment. However, not all reports on
CAL patients have been favourable.
Strumpf and co-workers (1991)
enrolled 19 patients with CAL into a
randomised, crossover designed study
comparing three months of nocturnal
ventilatory support using a bi-Ievel
positive pressure device (BiPAP,
Respironics, Murrysville, USA) with
"standard care". Only seven patients
were able to complete both arms of
this study, and the authors reported no
benefit from BiPAP treatment in terms
of improvements in gas exchange or
pulmonary indices. The differences in
results possibly arise from patient
selection in the various studies. It
appears that the sub-group of patients
with CAL likely to show improvement
from this form of therapy are those
with high levels of daytime CO
(Elliott et a11991, Hill 1993) who have
demonstrated severe respiratory gas
exchange abnormalities during sleep
(Elliott et a11992) and who are
~
figure 2.
Slow recording of oxygen saturation (Sa~2) and transcutaneous carbon dioxide (IcC02) in
a patient with neuromuscular disease. With the addition of supplemental oxygen,
baseline Sa02 (solid line) is improved but at the expense of acute CO2 retention (dashed
line).
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unresponsive to maximal conventional
medical therapy. It also appears that
acclimatisation to the technique and
adequate patient education are
essential elements for the success of
this treatment long term, with those
patients who are admitted to hospital
for at least a few days to become
familiar with the technique (Elliott et
al 1992) doing better than those
treated as outpatients (Strumpf et al
1991).
Acute respiratory failure
With the success of mask ventilatory
support in patients with chronic
respiratory failure, many centres are
now assessing its use in patients with
acute respiratory failure. Reports of the
use of this technique in patients with
CAL (Brochard 1990), chronic heart
failure (Benhamou et al 1992),
pneumonia (Meduri et al 1989), post-
operative difficulties (Pennock et al
1994) and pulmonary oedema
(Lapinsky et a1 1994) have all appeared
in the recent literature, with success
rates between 70 and 80 per cent
reported (Hill 1993).
Exacerbation of CAL is the most
common cause of acute respiratory
failure in the majority of the stpdies
reported (Bott et al 1993, Brochard et
aI1990). Favourable outcomes with
the administration of NIPPV to this
population have included the successful
avoidance of endotracheal intubation,
improvement in gas exchange, reduced
length of intensive care stay and
reduced mortality.
Negative outcomes have also been
reported (Foglio et a11992), although
the ventilation protocol was
intermittent, with the patient using the
machine a couple of times a day for
varying periods. In those studies with
more favourable results, the patients
used ventilatory support almost
continuously, including sleep periods,
until their clinical status had improved.
Since the most severe alterations in
ventilation and blood gases will occur
during sleep (Bye et al 1990, Piper and
Sullivan 1994a) it seems reasonable
that ventilatory assistance used during
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this time will be most likely to produce
clinical improvements.
For patients with acute exacerbations
of underlying respiratory problems
such as CAL, use of nasal or full face
mask ventilation allows the
administration of higher
concentrations of oxygen to correct
hypoxia without causing unacceptable
rises in hypercapnia (Conway'et al
1993), and stabilises the patient's
condition until the acute events are
reversed. Although arterial oxygen
tensions are improved and COz
controlled in most patients, in those
with severe hypercapnia, further rises
with the initiation ofNIPPV may be
seen (MeechamJones et aI1994).
Therefore, intervention with nasal
ventilatory support in this population
must be used with caution, and should
be seen as an adjunct to conservative
therapy or when intubation and
mechanical ventilation is considered
inappropriatee
The application of mask ventilation
has been described as a difficult and
time-consuming procedure (Chevrolet
et aI1991). Although the technique
requires more skill than the application
of oxygen therapy, the availability of
continuous monitoring devices for
SaO and TcCOz as well as staff
familiar with the technique and skilled
in its application, have seen this
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technique developing as an effective
and safe alternative to invasive
ventilation. This allows treatment to
be carried out on a general respiratory
ward (Elliott et al1990, Piper et al
1992). In many patients, exhausted by
their deteriorating condition and
inability to sleep for prolonged periods
because of abnormal breathing, the
introduction of mask ventilation will
relieve hypoxia and hypercapnia and
reduce the respiratory work, allowing
the patient the chance to achieve long
periods of deep sleep. Once this is
achieved, little nursing care is required,
although careful monitoring for safety,
adjustments to ventilator settings and
reduction of mouth and mask leaks will
be necessary to ensure that the best
level of ventilation is achieved.
Appropriate patient selection and skill
with the technique are necessary for
the technique to be effective. The
patient needs to be cooperative and not
at risk of aspiration (Batt et a11993)
and should be able to clear secretions
effectively either on their own or with
assistance (Elliott et alI990). During
ventilation for acute respiratory failure,
ventilatory assistance may be required
for most of the 24 hour period, with
the mask being removed for short
periods only to allow speech, coughing
and so on. As the patient's condition
improves, periods on the machine are
reduced as tolerated, although
Figure 3.
Mouth leaks may cause significant loss of ventilation especially with volume preset
devices. In this patient with poliomyelitis, good support of ventilation occurred during
wakefulness with the patient's mouth closed (indicated by black bar), and
transcutaneous carbon dioxide (1cCOz) levels fell (dashed line). However, with the onset
of sleep, the patient's mouth opened, .·educing ventilation and TeC02 rose. The patient
woke, closed the mouth, and TcCOzfeU again as ventilation improved. This continued
throughout the night until a chinstrap was added. The patient was receiving
supplemental oxygen during ventilation, so oxygen saturation (SaOz) was insensitive in
gauging the effectiveness of ventilatory support.
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nocturnal ventilation may continue for
some time and may be necessary on a
long term basis.
Weaning from
conventional ventilation
For a small number of patients
requiring intubation and mechanical
ventilation, withdrawal from
ventilatory support will pose a clinical
problem. This is most likely to be seen
in patients with pre-existing
respiratory pathology, where increased
work of breathing or impaired
respiratory drive already exists (Marini
1991).
Several published reports have
described the value ofNIPPV in
weaning patients from invasive
ventilation. Restrick et al (1993b)
reported 14 patients with weaning
difficulties who were commenced on
NIPPV after extubation or when the
patients were being supported by
synchronised intermittent mandatory
ventilation (SIMV) with a rate of less
than five breaths per minutew These
authors reported an 87 per cent success
rate with this technique. Udwadia et al
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(1992) used NIPPV to facilitate
weaning in a series of 22 patients and
were able to successfully wean 20
patients from invasive support. The
successful transfer from tracheal to
nasal ventilatory support has also been
reported in patients requiring long
term nocturnal ventilatory support
(piper et aI1994b).
"In patients where weaning difficulties
become apparent or are anticipated,
nasal ventilation can be used to assist
breathing in order that reintubation is
avoided or progression to
tracheostomy is not required. Even
when tracheostomy has occurred and
ventilatory support is required only
intermittently, use of nasal ventilation
can allow the removal of the tube,
which can improve spontaneous
breathing (Criner et al 1987) and
reduce the complication of care such as
suctioning and communication.
Devices for non-invasive
ventilatory support
Until a few years ago, the majority of
devices available for home ventilation
were volume preset (for example PLV
100, Lifecare, Boulder CO). With
these devices, a guaranteed tidal
volume is delivered from the machine
in the absence of a leak, with peak
inspiratory pressures varying
depending on the patient's chest wall
and lung compliance. These machines
are usually used in either assist-control
or control mode. At our centre, the
assist-control mode of operation,
whereby the clinician sets the
respiratory rate of the machine to
capture that of the patient, is preferred
but if the patient requires any
additional breaths, these will be
delivered.
More recently, pressure preset
devices designed for noninvasive
ventilatory support have become
available (BiPAP, Respironics,
Murrysville, Pennsylvania; VPAP,
Rescare, Sydney), and are gaining
popularity due to their simplicity,
lower cost and comfort. These bi-Ievel
airway pressure devices cycle between
two levels of pressure. During
inspiration a preset pressure (IPAP) is
generated, which terminates when a
certain time has elapsed (usually 3
seconds) or if flow falls below a
percentage of the peak inspiratory
flow. End expiratory pressure (EPAP)
is maintained at a lower level, and is set
according to the need for upper airway
splinting. With the BiPAP device, the
most commonly used machine, three
different modes ofventilatory support
are available. The VPAP device
operates in the spontaneous mode
only. In the spontaneous mode, the
patient determines the respiratory rate
and inspiratory time. In the
spontaneous timed (SIT) mode, the
operator sets a minimum rate, whereby
the machine will deliver backup
breaths if the patient rate falls below a
certain frequency. In the timed mode
(T), the machine is set to deliver all
breaths, determining not only
respiratory rate but also inspiratory
time. The tidal volume the machine
delivers will depend on the difference
between the IPAP and EPAP settings,
and the interplay between these
pressures and chest wall compliance
(MeechamJones and Wedzicha 1993).
Comparison studies examining the
-
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efficacy of the volume cycled and
pressure preset machines are few
(MeechamJones and Wedzicha 1993;
Restrick et aI1993a). However, it
appears that both devices can provide
similar quality ventilation in patients
with low or normal chest wall
impedance. In patients requiring high
inflation pressures due to low chest
wall or lung compliance, volume cycled
ventilators appear to be more likely to
control nocturnal blood gases than the
BiPAP device (Simonds and Elliott
1994).
Implementing and monitoring
nasal ventilatory support
For patients with chronic respiratory
failure, the clinical practice at the
Royal Prince Alfred Hospital Centre
for Respiratory Failure and Sleep
Disorders is to admit the patient to
hospital for the inirial trials of
ventilation in order to maximise the
effectiveness and minimise
complications associated with the
technique. Practice sessions during the
day provide an opportunity to become
familiar with the mask and the delivery
of air from the machine. Initial
machine settings are based on the
patient's level of comfort and their
daytime breathing characteristics.
Once the patient is acclimatised to the
technique, ventilator parameters are
adjusted to achieve the most effective
level of ventilatory support, based on
SaO and CO2 levels. The patient is
then
2
introduced to the device for
nocturnal use, again with at least 8a02
and TceO monitoring as basic guides
to the effedtiveness of the technique in
maintaining ventilation. Once
nocturnal ventilation is established,
early morning arterial blood gases are
taken to verify that ventilatory support
has been effective overnight.
In the acutely unwell patient
presenting with an acute deterioration,
ensuring suitable settings and
synchronisation between machine and
patient is imperative both for the safety
of the patient and for a positive
outcome to therapy. In this situation,
monitoring of SaOJand TcC02 needsto be supplemente by arterial
~-_.""......
Figure 4.
The top panels illustrate non-rapid eye movement (NREM) and rapicl.ey~ mov~ment (~EM)
sleep in a patient with chronic airflow limitation and REM hypoventllatlon USU1Q a bllevel
ventilatory support device in the spontaneous mode. Abbreviations are the same as th~se
used in figure 1, with the addition of oxygen saturation (Sa02) and pressure (representing
the inspiratory and expiratory phases of the machine, with inspj~ati~n indi..cated ~V an lip
deflection). Poor synchronisation between the patient and maclune IS ObVIOUS, with
significant desaturation in REM sleep. The lower panels demonstrate the improved
synchronisation and ventilatory support provided by the machine when a chinstrap was
used to minimise mouth leal<s.
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provides information about the quality
of the breath delivered and problems
such as leak or upper airway
obstruction which may occur during
treatment.
The most commonly observed event
likely to affect the adequacy of mask
ventilation is mouth leaks. Although
the pressure preset devices are said to
be more effective in compensating for
these leaks (Braghiroli and Donner
1992), clinically we have found
significant leaks can occur with either
device" The BiPAP device may sense
the mouth leak as patient flow and
therefore maintains IPAP for up to the
maximum 3s periodG In severe cases,
only every second or third breath will
be supported, which can produce poor
ventilation and oxygen desaturation.
With volume preset devices, peak
inspiratory pressure will drop in the
presence of mouth leaksG Robert et al
(1991) found that when patients are
monitored nocturnally, mouth leaks
were observed 100 per cent of the
time, although the effect on ventilation
efficacy was variable. Mouth dryness is
indicative of significant mouth leaks
with both types of devices, and can be
relieved by the use of a humidifier (eg
He 100, Fisher and Paykel, NZ).
However, attention to the underlying
problem, that is, minimising mouth
leaks, is a more sensible approach to
the problem and will often lead to
better augmentation ofventilation
(Figure 4)G
Clinical experience with non...
invasive ventilatory support
In the following section, the use of
nasal ventilatory support in a
population of patients with
hypercapnic respiratory failure
presenting to a respiratory medical
ward is reported to demonstrate how
the technique is used in clinical
practice and to outline some of the
practical issues likely to be
encounteredG It should be noted that a
volume preset device was used for all
patients, as that was the only type of
ventilator available when this study was
performedG However, many of the
patients described would now be
trialled on a pressure preset device.
-
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sleep. It needs to be understood that
the response-latency with TcCO is
. z
prolonged (up to three ffilnutes), and
although this device does not permit
the recording of transient alterations in
COz' progressive CO2 rises from
IJ)outh leaks (Figure 3), or hypocarbia
from overventilation will be detected.
Titration of inspiratory and
expiratory pressures for patients on a
pressure preset device or tidal volume
for a patient using a volume cycled
ventilator is made on the basis of
maintaining or improving saturation
and carbon dioxide values whilst
ensuring patient-ventilator synchronYG
Recording of chest wall movement (for
example with inductive
plethysmography or strain gauges) or
measurement of diaphragm activity
will provide essential information
about the patient's spontaneous
breathing efforts and the delivery of
tidal volume or pressure from the
ventilator. Airway pressure is a valuable
parameter to measure, particularly
with volume preset machines, as it
~O,:'-,:'
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figure 5.
Changes in daytime partial-pressure of arterial oxygen (PaC) (solid circles) and carbon
dioxide (PaC02) (solid stars) with the introduction of short...te
2
rm nasal ventilation. Data
are mean (SE)G NIPPV - Nasal positive pressure ventilation.
punctures to ensure the adequacy of
ventilatory support so that decisions
about alternative methods such as
intubation can be made quicldYG
Meduri et al (1991) demonstrated that
if gas exchange failed to improve
within the first few hours of
commencing ventilation, later success
was unlikelYG
The parameters monitored during
nasal ventilation in the hospital setting
will depend greatly on the equipment
available, the preferences of the
clinician setting the device, and the
aim of theraPYG As stated previously,
our unit considers SaOz and TcCO
monitoring as fundamental z
measurements in ensuring the
adequacy and safety of nasal ventilatory
support.lIovvever, there is some
debate in the literature regarding the
accuracy ofTcCOz monitoring in this
population, particularly with high
levels of COz (Sanders et al 1994). In
our experience, TcCOz monitoring has
been invaluable in reflecting trends in
ventilation, both awake and during
Figure 6.
Awake daytime partial pressure of arterial carbon dioxide (PaCOz) values prior to(hatched bars) and after (clear bars) the commencement of NIPPV for each of the
diagnostic groups treated. Due to the small numbers of patients with chest wall disorders
seen (n =3), statistical analysis was not performed. Error bars indicate SE.
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Methods
The records of 29 consecutive patients
referred to our unit for mask
ventilation over a 12 month period
were reviewed. Respiratory failure in
the patients seen was due to a range of
causes: six patients presented with
neuromuscular disease, three had chest
wall dysfunction, 13 had obesity-
hypoventilation (ORS) unresponsive
to conventional CPAP therapy and
seven patients had end stage lung
disease (chronic airflow limitation or
cystic fibrosis). The clinical condition
and histories of all patients suggested
that an element of sleep disordered
breathing was contributing to their
respiratory failure. Twenty-two
patients underwent full sleep studies
immediately prior to commencing
mask ventilation, and confirmed
nocturnal hypoventilation with
significant CO2 retention" Sleep studies
were performed using standard
techniques and included monitoring of
electroencephalographic (EEG) and
electrooculargram (EGG),
electromyographic (EMG) activity of
the genioglossus and diaphragm, nasal
airflow, chest wall movement, Sa02
and TcC02• All variables were
recorded continuously on a 12 or 16
channel polygraph.
The decision to commence non-
invasive ventilation was made in one of
the following circumstances:
a) acute respiratory decompensation
despite maximum conventional
therapy, where intubation and
lCU management was deemed
inappropriate, usually because
difficulties in weaning were
anticipated;
b) failure to respond to CPAP
therapy due to tolerance, or failure
of the device to prevent significant
hypoventilation with marked
worsening of hypercapnia during
sleep and/or failure to reverse
daytime hypercapnia; and
c) stable chronic respiratory failure
due to hypoventilation during
sleep in neuromuscular or chest
wall diseases.
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Ventilation technique
Mask ventilation was commenced on a
general respiratory ward with
continuous monitoring of SaQ) and
TcC02 to guide the settings ot
ventilation parameters and ensure the
adequacy of the technique. In general,
ventilation was recommended for
nocturnal use only, with short daytime
sessions to familiarise the patient with
the technique. However, if patients
were obnmded or exhibited signs of
fatigue, ventilatory support was used
continously until the patient's clinical
condition improved. A volume-cycled
ventilator was used (PLV-lOO, Medical
Gases ofAustralia), with an
appropriately chosen commercial nasal
mask (Sullivan™, Rescare, Sydney). In
the deeply obtunded patients, a full
face mask was necessary if significant
mouth leaks could not be controlled by
a chin strap. The assist/control mode
of ventilation was used and, where
possible, the patient was slightly
hyperventilated in order to capture and
control respiratory pattern. A positive
end expiratory pressure (PEEP) valve
was added to the expiratory port of the
ventilation tubing if residual upper
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airway obstruction was noted.
Prior to commmencing ventilation,
arterial blood gas measurements
(ABGs) were taken in the late morning
or during the afternoon from the radial
artery, with the patient awake and, if
possible, breathing room air.
Additional blood gas sampling was
performed at 0600 hours with the
patient on the ventilator to check the
efficacy of overnight ventilation and to
check for any drift in the reading of the
TcCOz monitor. Blood gas values
reported were obtained prior to
commencing ventilation and again
prior to hospital discharge, and with
the patient breathing spontaneously.
Statistics
Data are presented as mean(SE).
Comparisons between measurements
taken prior to ventilatory support and
after stabilisation were made using
paired t tests. Comparisons made
between patients presenting with acute
and chronic respiratory failure were
made using unpaired t tests.
Differences between diagnostic groups
were analysed using analysis of
variance for repeated measures.
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Results
Clinical outcomes
In all patients, significant
improvements in ABGs were achieved
during the hospital stay. As a group,
PaC02 fell from 64(2) to 50(1) mmHg(p < 0.001), while PaOz improved from
55(2) to 68(2) mmHg (p < 0.001)
during a mean ventilation time of
10(0.8) days (Figure 5). Analysis of data
according to patient diagnosis
demonstrated that all subgroups
responded with a similiar fall in PaCOz
and improvement in PaOz after the
introduction of nasal ventilation
(Figure 6, Table 2). In looking at
response to treatment based on
whether the patient presented with
acute or chronic respiratory failure,
both groups responded similarly. As
expected, patients presenting with
acute decompensation (ARF) had a
significantly higher PaC02 level than
patients with chronic stable respiratory
failure (CRF) (73(3) vs 58(2) mmHg,
p =0.001). However, after ventilation,
there was no difference in CO2 levels
between the two groups (52(3) vs 49(1)
mmHg, p =0.42) (Table 3).
There were no differences in the
ventilator settings used for patients
presenting with acute respiratory
failure compared with chronic
respiratory failure (Table 3). However,
there were differences in the peak
airway pressures required to ventilate
the two groups effectively. Patients
with acute respiratory failure required
significantly higher inspiratory
pressures to maintain effective
ventilation during sleep (ARF: 28(1)
cmH20 vs CRF: 23(1) cmH20,P=0.009).
In patients with primary lung disease,
higher tidal volumes with greater peak
airway pressures were required to
achieve acceptable ventilation
compared with the other diagnostic
groups (Table 4), with a greater
likelihood of air leakage, particularly
~
Differences were considered significant
at the 0.05 leveL Analysis was
performed using the Excel statistical
package (Microsoft, Version 5).
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through the mouth, and a higher risk
of air swallowing. Despite this,
significant improvements in PaC02
were achieved in these patients, with a
fall in PaCOz from 78(5) to 61(2)
mmHg after ventilation (p =0.007).
However, the PaCOzlevel post
ventilation remained significantly
higher than for other groups
.(P(2Sl) = 10.01; compared with OHS
group: t(7) = 5.96;p < 0.001; compared
with neuromuscular group: t(9) =2.96;
P< 0.009).
Often, clinical and subjective
improvements were seen within the
first day or two of commencing
NlPPV, with physiological
improvements following several days
later. In those patients where full
polysomnography was performed on
the first night of ventilation (n =6),
long periods of slow wave (SWS) and
REM sleep were seen, despite mouth
and mask leaks and the novelty of the
situation for the patient.
In all patients, commercially available
masks were used. Full face masks were
needed by three patients to minimise
mouth leaks. One patient found the
nasal mask claustrophobic and nasal
prongs (Adam Circuit, Puritan Bennett
Corp, Lenexa, Kansas, USA) were used
in this instance. In 21 patients, nasal
clips or "Bubble" cushions (Sullivan™,
Rescare, Sydney) were utilised to
minimise mask leaks whilst exerting
minimal pressure on the skin.
The technique was well accepted,
with 23 of the 29 patients sleeping
most of the night on the device by the
second night of therapy.
Complications
Side effects caused by the technique
did occur, but these were minor and
did not prevent the patient from
continuing with ventilation. Air
swallowing with abdominal distension
was the most frequent complaint,
occurring in seven of the 29 patients.
The other group of problems related
to leaks from the mouth or mask.
These were managed by changing the
mask type or introducing a chin strap.
Twenty-four of the 26 patients using a
nasal mask or nasal prongs required a
chin strap.
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Post-hospital management
Prior to hospital discharge, 15 patients
were transferred to nocturnal CPAP
therapy, with six of these also requiring
supplemental oxygen. In another
patient, nocturnal oxygen alone was
prescribed. The remaining 13 patients
continued on nasal ventilation on a
domiciliary basis in order to maintain
daytime blood gases and prevent
nocturnal hypoventilation, after sleep
studies showed that nocmrnal
hypoventilation persisted and could
not be controlled by oxygen and/or
CPAP.
Discussion
The results of this study demonstrate
that nasal mask ventilation is an
effective and well-tolerated method of
reversing or minimising daytime
carbon dioxide retention. The
technique can be carried out on a
general ward, and can be used for
short-term continuous support or
long-term nocturnal treatment of
patients with either chest wall
restriction or airway obstruction.
In all patients reported in this present
study, significant improvements in
PaCO occurred whilst in hospital,
regardless of the underlying diagnosis.
These findings differ somewhat from
Gay and co-workers (1991) where only
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minor changes in daytime CO2 values
were achieved in their patients during
hospitalisation. Part of this difference
may have been our greater use of chin
straps to minimise mouth leaks and
therefore optimise ventilation
nocturnally. Gay and co-workers
(1991) reported that only six of their
26 patients wore chin straps, whereas
24 of our 26 patients using nasal masks
or prongs wore one, with the other
three patients using a full face mask.
Although some patients may not be
able to tolerate chin straps initially,
once they were familiar with the
technique, chin straps, in general, were
readily accepted. Air leaks at the
interface betw"een face and mask or
through the mouth commonly occur
and are often unavoidable. With this
technique, some air leakage has to be
accepted as long as effective ventilation
is maintained and the leakages do not
cause frequent arousals from sleep. We
have found that leaks frequently
decrease as the patient becomes more
accustomed to the device.
To a large extent, the efficacy of the
technique and the tolerance of the
patient to it depends extensively on
maximising the effectiveness of
ventilation whilst minimising
problems. Various studies from other
units overseas report a rate of failure of
patients to tolerate NlPPV therapy of
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between 19 and 36 percent (Gay et al
1991, Strumpf etaI1991).This has not
been our experience in either short or
long term follow up series. The better
results reported here may reflect
differences in patient selection,
therapist input, or our more aggressive
approach to minimising mouth leaks
and maximising ventilation.
Unlike many colleagues overseas, we
have experienced few problems with
the discomfort or skin damage so
frequently attributed to commercially
available masks. Bach (1992)
commented that commercially
available masks may not be adequate
for the higher flows needed for
ventilation and suggested that custom
moulded interfaces needed to be
constructed for about 50 per cent of
patientsusingNIPPV. However, such
a task is more cosdy, time consuming
and requires a certain degree of
expertise, which may deter those new
to the·area from trialling this non-
invasive technique. In the present
study, all patients were ventilated using
commercially available masks. In the
majority of cases, Bubble masks or
clips were necessary to provide greatest
patient comfort and leak minimisation.
However,the need for a comfortable
and effective full face mask remains,
particularly for use during
management of acute respiratory
failure.
It is important to recognise that the
first few nights ofsleep on the
ventilator will be different from
subsequent sleep, and for that reason
the patient should be monitored and
observed closely during the initial trials
of nasal ventilation. Rebound of slow
wave and REM sleep, along with
depression of arousal responses which
can occur during initial treatment trials
(BerthonJones and Sullivan 1987,
Piper and Sullivan 1994a) requires
careful observation and supervision of
the patient to ensure the efficacy of the
technique and the safety of the patient.
Side effects
A number of adverse effects have been
reported with the use ofnasal
ventilation. In most cases, these
problems pose an inconvenience to the
patient but generally do not cause
oRIGI NA 1 ART I C LE
treatment to be abandoned. However,
ifthese problems can be addressed and
solved, quality oflife and satisfaction
with treatment long term will be
improved.
Gastric distension caused by air
swallowing is most commonly seen in
patients with low chest wall
compliance (such as lung disease) or
with weakness ofthe gastric sphincter.
Up to 50 per cent of patients on
volume preset ventilators may report
gastric distension ·at some time during
treatment (Leger 1994), although it is
less likely to be seen with pressure
preset devices. The administration of
peppermint water prior to sleep,
sleeping with the left side down and
maintenance of minimum effective
ventilator pressures are all useful
strategies to combat this problem.
Dryness of the mouth suggests oral
leakage, and although it can be
managed with humidification,
attention to minimising the leak can
also improve ventilation efficacy.
Patient education
Although nasal ventilation is an
effective treatment for hypercapnic
respiratory failure, it should not be
assumed that it is either appropriate or
suitable for all individuals.. Before
instituting long term home therapy,
consideration must be given to the
patient's overall clinical picture, their
coping mechanisms and degree of
social support. In those patients with
progressive disorders, such as motor
neurone disease or Duchenne muscular
dystrophy, frank discussion about the
ongoing development of respiratory
muscle weakness, and therefore the
possibility ofventilator dependence, is
essential. In these patients,the primary
aim of nocturnal ventilatory support is
to improve daytime.symptoms and
overall quality of life, rather than
simply prolonging survival. Discussion
about commencing nocturnal
ventilation must also raise issues
regarding the patient's wishes with
respect to eventually extending
ventilator use into the daytime. This
includes eventual ventilator
dependence or palliative care measures,
and the implications of a tracheostomy
for someone with upper limb paralysis
and possible bulbar dysfunction. Such
decisions are difficult but need to be
considered outside of an emergency
situation, as once a tracheostomy is
performed it cannot always be easily
reversed in these patients. We have
found that many individuals and their
families in this situation are not
prepared for the limitations such a
procedure can have on lifestyle,
resources and quality oflife.
Follow up
Acceptance of this form oftherapy in
both the short and long term depends
greatly on relieving or improving the
patient's symptomatology whilst
minimising the side effects and
inconveniences of the treatment. For
the majority of patients, the benefits of
therapy outweigh the inconveniences,
with compliance rates of 90 percent
being reported in follow up (Potter et
aI1994). This is substantially higher
than compliance rates for mask CPAP
in patients with obstructive sleep apnea
(Kribbsetal 1993). Once commenced
on treatment, regular follow up is
necessary to review ventilation. settings
and check the functioning of
equipment. Over time, ventilation
requirements and settings can change,
particularly if patients have underlying
pathology which is progressive, if
weight is gained or lost, or if upper
airway obstruction develops.
Daytime blood gases and lung
function provide limited information
about overall.progress. Full nocturnal
polysornnography will identify more
subtle problems and technical
difficultieswhich.may be causing
daytime symptoms. This is particularly
important for .patients with progressive
disease, to distinguish between
progression of their primary disease
process.and problems of inadequate
ventilation.
Conclusion
Over the past decade, non-invasive
nocturnal ventilatory support has
emerged as an effective and acceptable
method of reversing daytime
hypercapnia and improving the clinical
condition and quality of life in patients
...
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with a wide range of pathologies
causing nocturnalhypoventilation.
With the continued development of
ventilatory support devices and
interfaces, the technique is becoming a
reasonable treatment option for
patients with both acute as well as
chronic respiratory failure.. An
understanding of the various devices
available, and the problems likely to be
encountered with each, is becoming an
essential skill for any professional
working with patients with respiratory
insufficiency. Physiotherapists are well
placed to be part of that team, in both
the assessment.andmanagement of
patients with established respiratory
failure or those at risk of developing it.
This technique can be used as part of
an overall respiratory care program to
greatly enhance the care of patients
with hypercapnic respiratory failure.
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